12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

Affitech cancer news

Affitech shareholder Trans Nova Investments Ltd. acquired 25.1 million shares in Affitech for DKK0.20 per share in cash, or DKK5 million ($846,038). The...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >